معرفی
Dr. Paul Clark is an Honorary Professor at the University of Queensland's National Centre for Youth Substance Use Research, with extensive contributions to hepatology and Indigenous health research. His work focuses on liver disease, viral hepatitis, and substance use, particularly examining health disparities among First Nations Australians.
- University of Queensland, National Centre for Youth Substance Use Research
- Active researcher with publications through 2025
- Specializes in liver disease and Indigenous health disparities
Professor Clark's research primarily centers on hepatology, with a strong emphasis on understanding and addressing health disparities in Indigenous populations. His work spans viral hepatitis treatment outcomes, cirrhosis management, and substance use disorders, particularly examining how these conditions intersect in vulnerable populations. He has made significant contributions to understanding treatment outcomes for hepatitis C in diverse populations and has developed tools for assessing substance use behaviors.
His recent publications (2022-2025) demonstrate a consistent focus on liver disease in Indigenous populations, with particular attention to cirrhosis, hepatocellular carcinoma, and hepatitis C treatment outcomes. The research shows a strong pattern of examining health disparities, treatment access issues, and the impact of comorbidities on disease progression. His work frequently employs large-scale data linkage studies and multicenter collaborations to address these complex health issues.
Professor Clark has collaborated extensively with researchers across Australia, particularly focusing on First Nations health outcomes. His work demonstrates strong engagement with clinical practice and health policy, aiming to translate research findings into improved care models for vulnerable populations.
His research team appears to focus on liver disease and substance use, with particular attention to Indigenous health disparities. The work often involves multicenter collaborations across Australian healthcare institutions, suggesting a broad research network focused on improving liver disease outcomes and addressing substance use disorders in vulnerable populations.
